Patent details

Basic Information

Publication number:

EP2917230

PCT Application Number:

EP2013073602

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137928834

PCT Publication Number:

WO2014072526

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DEVELOPMENT OF HBV- AND/OR HDV-SUSCEPTIBLE CELLS, CELL LINES AND NON-HUMAN ANIMALS

French Title of Invention:

DÉVELOPEMENT DE CELLULES, LIGNÉES CELLULAIRES ET ANIMAUX NON HUMAINS SENSIBLES À HBV ET/OU HDV

German Title of Invention:

ENTWICKLUNG VON HBV- UND/ODER HDV-EMPFÄNGLICHEN ZELLEN, ZELLLINIEN UND NICHTMENSCHLICHEN TIEREN

SPC Number:

Dates

Filing date:

12/11/2013

Grant date:

18/07/2018

EP Publication Date:

16/09/2015

PCT Publication Date:

15/05/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/07/2018

EP B1 Publication Date:

18/07/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/11/2018

Expiration date:

12/11/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/07/2018

 

 

Name:

Ruprecht-Karls-Universität Heidelberg

Address:

Grabengasse 1, 69117 Heidelberg, Germany (DE)

Inventor

1

Name:

NI, Yi

Address:

Germany (DE)

2

Name:

URBAN, Stephan

Address:

Germany (DE)

Priority

Priority Number:

201261725144 P

Priority Date:

12/11/2012

Priority Country:

United States (US)

Classification

IPC classification:

A01K 67/027; C07K 14/705; G01N 33/50; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

201829

Publication date:

18/07/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/03/2019	Outgoing Correspondence	1